SCHEMBL30469181

SCHEMBL30469181

CC(CO)Cc1ccc(C2CCC3(CC2)OCCO3)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPV3 Q8NET8 1/20 0.38
C5AR1 P21730 9/20 0.37
ABL1 P00519 3/20 0.36
PDE10A Q9Y233 1/20 0.36
PNMT P11086 1/20 0.35
OPRD1 P41143 2/20 0.34
OPRL1 P41146 2/20 0.34
OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25218889 1.00 TRPV3 (0.38) TRPV3C5AR1ABL1PDE10APNMT
SCHEMBL30469196 1.00 TRPV3 (0.38) TRPV3C5AR1ABL1PDE10APNMT
SCHEMBL31067853 1.00 TRPV3 (0.38) TRPV3C5AR1ABL1PDE10APNMT
SCHEMBL25250725 1.00 TRPV3 (0.38) TRPV3C5AR1ABL1PDE10APNMT
SCHEMBL25250727 1.00 TRPV3 (0.38) TRPV3C5AR1ABL1PDE10APNMT
SCHEMBL25236451 0.84 C5AR1 (0.41) C5AR1OPRD1OPRL1OPRK1
SCHEMBL25236450 0.84 C5AR1 (0.41) C5AR1OPRD1OPRL1OPRK1
SCHEMBL25213573 0.84 C5AR1 (0.41) C5AR1OPRD1OPRL1OPRK1
SCHEMBL25240948 0.82 C5AR1 (0.36) C5AR1PDE10APNMTOPRD1OPRL1
SCHEMBL25240728 0.82 C5AR1 (0.36) C5AR1PDE10APNMTOPRD1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436976-A1 SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION Genentech, Inc. (US) 2024-10-02 EP disclosed
CN-118510783-A Spiro modulators of cholesterol biosynthesis and their use for promoting remyelination 基因泰克公司 2024-08-16 CN disclosed
WO-2023097234-A1 SPIROCYCLIC MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATION GENENTECH, INC. (US) 2023-06-01 WO disclosed